Investor Information
Annual Report
Annual Report 2013-14
Annual Report of India Subsidiary Companies 2013-14
Annual Report of Overseas Subsidiary Companies 2013-14
1. Ranbaxy Malaysia Sdn. Bhd., Malaysia
4. Ranbaxy (S.A.) (Proprietory), South Africa
5. Sonke Pharmaceuticals (Pty) Ltd.
6. Ranbaxy Egypt (L.L.C.), Egypt
7. Rexcel Egypt (L.L.C.), Egypt
8. Ranbaxy (U.K.) Ltd., United Kingdom
9. Ranbaxy Poland S.P. Z.o.o., Poland
10. Ranbaxy Nigeria Ltd., Nigeria
11. Ranbaxy (Thailand) Company Limited, Thailand
14. Ranbaxy Farmaceutica Ltda., Brazil
15. Ranbaxy PRP (Peru) S.A.C., Peru
16. Ranbaxy Europe Ltd., United Kingdom
18. Ranbaxy Pharmaceutical, Inc. USA
21. Ranbaxy Laboratories Inc., USA
22. Ranbaxy Signature LLC, USA
23. Ranbaxy (Netherlands) B.V. (“RNBV”), The Netherlands
27. Ranbaxy Pharmacie Generiques SAS, France
28. Ranbaxy Portugal – Com E Desenvolv De Prod Farmaceuticos Unipessoal Lda, Portugal
29. Laboratorios Ranbaxy, S.L., Spain
30. Office Pharmaceutique Industriel Et Hospitalier SARL (“OPIH SARL”), France
31. Ranbaxy Australia Pty. Ltd., Australia
32. Ranbaxy Pharmaceuticals Canada Inc., Canada
33. Ranbaxy Italia S.p.A Italy
35. Ranbaxy Belgium N.V., Belgium
36. Be-Tabs Investments (Proprietary) Ltd., South Africa
37. Be-Tabs Pharmaceuticals (Proprietary) Ltd., South Africa